Project Grant R37CA303326
Award Date 9/19/25
Completion Date 8/31/30
Dollars Obligated $681K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Texas, USA
Similar Awards
- The University of Texas MD Anderson Cancer Center was awarded a $210,003 Project Grant by the National Cancer Institute (NCI) under the Cancer Research Manpower (CFDA 93.398) program. The grant will fund a 5-year project to evaluate dietary changes and a Mediterranean diet intervention among medically underserved men with prostate cancer, with a focus on African American and low socioeconomic status men who face higher risks of adverse prostate cancer outcomes. The project aims to define dietary...
- The National Cancer Institute (NCI) awarded a $825,966 Project Grant to the University of Texas MD Anderson Cancer Center under the Cancer Cause and Prevention Research (CFDA 93.393) federal grant program. The grant, which has an award date of September 4, 2025 and an ultimate completion date of August 31, 2030, will fund a randomized controlled trial to test the effects of a multilevel, culturally adapted storytelling intervention. The intervention aims to address stigma at both the patient and...
- The National Cancer Institute awarded a Project Grant under the Cancer Detection and Diagnosis Research program (CFDA 93.394) to Colorado State University in the amount of $414,446 on March 14, 2025. The grant will fund a 12-week group-based videoconference intervention to increase moderate to vigorous physical activity (MVPA) in cancer survivors. The intervention will include twice-weekly instructor-led aerobic and resistance exercise sessions, as well as PA behavior change discussions. The...
- This Project Grant award of $704,882 from the National Cancer Institute (NCI), under the Cancer Cause and Prevention Research program (CFDA 93.393), supports research to define the genetic factors underlying familial prostate cancer in African American men. The project aims to develop risk prediction models that incorporate polygenic risk scores, pathogenic variants, and family history to provide more accurate information about genetically-informed treatment, risk for second cancers, and...
- The Defense Health Agency awarded a $468,672 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to Georgia College & State University. The grant, titled "The Inclusive Cancer Care Research Equity (ICCARE) for Black Men Consortium," will fund research focused on examining health-seeking behaviors, decision-making, psychosocial effects, and coping mechanisms among Black men with prostate cancer. The project will also test the efficacy of...
- This federal Project Grant award, totaling $477,869.00, was provided by the National Cancer Institute (NCI) under the Cancer Treatment Research program (CFDA 93.395). The grant aims to develop tailored, multilevel cervical cancer interventions for ethnically diverse Black women, including African American women and Black African immigrant women. The key objectives are to: 1) identify multilevel determinants of routine cervical cancer screening and follow-up adherence among these populations,...
- This Project Grant award from the Defense Health Agency, under the Military Medical Research and Development program (CFDA 12.420), provides $1,444,922.00 to the University of Texas MD Anderson Cancer Center (MD Anderson) to conduct research on a novel epigenetic determinant in metastatic prostate cancer. The award period is from September 15, 2024 to September 14, 2027. MD Anderson, a comprehensive cancer research and treatment center, will utilize this funding to carry out basic,...
- This federal Project Grant award from the Defense Health Agency, under the Military Medical Research and Development program (CFDA 12.420), provides $1,882,607.00 to The University of Texas M.D. Anderson Cancer Center (MD Anderson) to conduct research on "LEVERAGING PROSTATE CANCERS' UNIQUE LIPID METABOLISM TO INDUCE THERAPEUTIC FERROPTOSIS." The award has a period of performance from March 15, 2025 to March 14, 2028 and aims to transform healthcare for military service members,...
- The National Cancer Institute (NCI) awarded a $2,561,113 Cooperative Agreement to The University of Texas MD Anderson Cancer Center on August 22, 2025 through the Cancer Centers Support Grants (CFDA 93.397) program. This funding will support a comprehensive research project titled "LYMPHOMA OUTCOMES SPORE - ACROSS LYMPHOMA SUBTYPES, AFRICAN AMERICAN (AA) AND HISPANIC PATIENTS EXPERIENCE MARKED DIFFERENCES IN AGE OF ONSET, DISEASE PRESENTATION, TREATMENT, AND SURVIVAL." The project aims...
- The University of Miami was awarded a $2,746,080 Project Grant from the National Cancer Institute (CFDA 93.393 Cancer Cause and Prevention Research) to conduct a study on the effects of remotely-delivered cognitive behavioral stress management (R-CBSM) on cancer-accelerated aging in older, distressed breast cancer survivors. The study will enroll 192 breast cancer survivors who have completed initial treatment within the last 3-12 months, are continuing on adjuvant endocrine therapy, and are...